Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,353 JPY | -4.35% |
|
-0.93% | -16.86% |
Business Summary
Number of employees: 843
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
88.3
%
| 14,991 | 86.1 % | 22,976 | 88.3 % | +53.26% |
Medical Devices
11.7
%
| 2,428 | 13.9 % | 3,034 | 11.7 % | +24.99% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
65.8
%
| 14,871 | 85.4 % | 17,123 | 65.8 % | +15.15% |
Japan
23.1
%
| 21 | 0.1 % | 6,021 | 23.1 % | +28,631.54% |
United States
11.0
%
| 2,527 | 14.5 % | 2,866 | 11.0 % | +13.41% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ying Luo
FOU | Founder | 57 | 01/05/01 |
Toshiya Kitagawa
DFI | Director of Finance/CFO | - | 03/23/03 |
Kanichiro Suzuki
BRD | Director/Board Member | - | - |
Thomas Eastling
BRD | Director/Board Member | 63 | 01/13/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hao Yan
BRD | Director/Board Member | 61 | - |
Hideaki Sashiwa
BRD | Director/Board Member | 66 | 01/08/01 |
Ying Luo
FOU | Founder | 57 | 01/05/01 |
Kazuki Sekitani
BRD | Director/Board Member | 68 | 30/23/30 |
Thomas Eastling
BRD | Director/Board Member | 63 | 01/13/01 |
Kanichiro Suzuki
BRD | Director/Board Member | - | - |
Kanako Kikuchi
BRD | Director/Board Member | 61 | 30/23/30 |
Ryosuke Matsui
BRD | Director/Board Member | 45 | 30/23/30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 50,001,743 | 48,311,320 ( 96.62 %) | 13,526 ( 0.0271 %) | 96.62 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
Gyre Therapeutics, Inc.
74.85% | 64,005,887 | 74.85% | 727,106,876 $ |
GNI GROUP LTD. 0.03% | 13,500 | 0.03% | 189,255 $ |
Company contact information
GNI Group Ltd.
Nihonbashi-Honcho YS Building, 3/F 2-2-2 Nihonbashi-Honcho
103-0023, Tokyo
+81 3 6214 3600
http://www.gnipharma.com![address GNI Group Ltd.(2160)](https://cdn.zonebourse.com/static/address/6814689.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.86% | 771M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+35.57% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- 2160 Stock
- Company GNI Group Ltd.